Influence of Ethylphenacemide on Serum Levels of Other Anti‐Epileptic Drugs
- 1 June 1970
- Vol. 11 (2) , 207-215
- https://doi.org/10.1111/j.1528-1157.1970.tb03882.x
Abstract
SUMMARY: Serum phenobarbital, phenytoin and primidone levels were determined before, during and after addition of ethylphenacemide to the medication of 7 male patients, all with normal liver function and blood counts. During ethylphenacemide medication, a statistically significant increase in levels of phenobarbital and phenytoin in the serum was found. Thus therapeutic and toxic effects of ethylphenacemide may be well due to this secondary action.RÉSUMÉ: Le taux sérique de phénobarbital, de phénytoïne et de primidone ont été mesures avant, pendant et aprés l'adjonction d'éthylphénacémide a leur thérapeutique chez 7 patients adultes ayant des fonctions hépatiques et une numération globulaire normales. Pendant la médication avec éthylphénacémide on a observé une augmentation significative du taux sérique de phénobarbital et de phénytoïne. II est done possible que les effets thérapeutiques et toxiques de l'ethylphénacémide soient dus en réalitéà cette action secondaire.Keywords
This publication has 6 references indexed in Scilit:
- Sulthiame (Ospolot®) as Inhibitor of Diphenylhydantoin MetabolismEpilepsia, 1968
- Phenytoin Intoxication during Treatment with Antabuse® (Disulfiram)Epilepsia, 1966
- DICOUMAROL-INDUCED DIPHENYLHYDANTOIN INTOXICATIONThe Lancet, 1966
- Depression of parahydroxylation of diphenylhydantoin by antituberculosis chemotherapyNeurology, 1966
- The estimation of some important anticonvulsant drugs in serumClinica Chimica Acta; International Journal of Clinical Chemistry, 1966
- Metabolic Conversion of Primidone (Mysoline) to Phenobarbital.Experimental Biology and Medicine, 1956